- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07685691
Relationship Between Clinical Status and Nerve Conduction Test Findings in Patients With Unilateral Hemiplegia
28. juli 2026 opdateret af: Baskent University
Prevalence of Peripheral Nerve Conduction Abnormalities and Their Association With Clinical Scores in Patients With Hemiplegia
Stroke-related hemiplegia may be accompanied by peripheral nerve conduction abnormalities, which may contribute to motor impairment and functional limitations.
However, the frequency of these abnormalities and their relationship with clinical status have not been fully characterized.
This single-center observational study aims to evaluate the frequency of peripheral nerve conduction abnormalities identified by nerve conduction studies in patients with unilateral hemiplegia and to examine their association with motor and functional clinical assessment scores.
The findings may contribute to a better understanding of peripheral nerve involvement in stroke rehabilitation.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This is a single-center observational study designed to evaluate peripheral nerve conduction abnormalities in patients with unilateral hemiplegia following stroke.
Participants undergo standardized nerve conduction studies together with routine clinical assessments, including validated measures of motor recovery and functional status.
The study aims to describe the frequency of peripheral nerve conduction abnormalities within the study population and to examine their association with clinical assessment scores.
The results may improve the understanding of peripheral nerve involvement in patients with hemiplegia and provide information that may be useful for rehabilitation practice.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
72
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Adana, Tyrkiet (Türkiye), 01250
- Başkent University Adana Dr. Turgut Noyan Application and Research Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Adults with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke who were recruited from the Department of Physical Medicine and Rehabilitation at a single tertiary care center.
All participants underwent standardized nerve conduction studies and clinical assessments according to the study protocol.
Beskrivelse
Inclusion Criteria:
- Adults (≥18 years of age).
- Unilateral hemiplegia secondary to ischemic or hemorrhagic stroke, or intracranial hemorrhage.
- Ability to undergo standardized nerve conduction studies and clinical assessments.
- Provision of written informed consent.
Exclusion Criteria:
- Bilateral hemiplegia.
- Hemiplegia secondary to benign or malignant intracranial tumors.
- Upper or lower extremity fracture, amputation, skin lesions preventing electrophysiological testing, or diagnosed peripheral vascular disease.
- Concomitant neurological disorders that may affect motor function or peripheral nerve conduction (e.g., Parkinson's disease, multiple sclerosis, encephalitis).
- Contraindications to nerve conduction studies (e.g., cardiac pacemaker or inability to safely undergo the examination).
- Inability to cooperate with or tolerate nerve conduction studies.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Patients With Unilateral Post-Stroke Hemiplegia
Patients with unilateral post-stroke hemiplegia who underwent standardized nerve conduction studies and clinical assessments, including motor and functional outcome measures.
|
Standardized motor and sensory nerve conduction studies were performed to evaluate peripheral nerve conduction abnormalities in patients with unilateral post-stroke hemiplegia.
The test was used as a diagnostic assessment and was not part of a therapeutic intervention.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Association Between Peripheral Nerve Conduction Abnormalities and Clinical Assessment Scores
Tidsramme: Baseline
|
To evaluate the association between peripheral nerve conduction abnormalities identified by standardized nerve conduction studies and motor and functional outcome measures in patients with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke.
Peripheral nerve conduction abnormalities identified by standardized nerve conduction studies will also be described.
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fugl-Meyer Assessment (FMA) Score (Upper and Lower Extremities)
Tidsramme: Baseline
|
Association between peripheral nerve conduction abnormalities and motor impairment assessed using the Fugl-Meyer Assessment.
|
Baseline
|
|
Functional Independence Measure (FIM) Score
Tidsramme: Baseline
|
Association between peripheral nerve conduction abnormalities and functional independence measured using the Functional Independence Measure.
|
Baseline
|
|
Timed Up and Go Test (TUG)
Tidsramme: Baseline
|
Association between peripheral nerve conduction abnormalities and mobility performance assessed using the Timed Up and Go test.
|
Baseline
|
|
Tetrax Fall Index
Tidsramme: At study enrollment (baseline)
|
The Fall Index was assessed using the Tetrax static posturography system.
Higher scores indicate a greater estimated risk of falling.
|
At study enrollment (baseline)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
4. oktober 2024
Primær færdiggørelse (Faktiske)
20. maj 2026
Studieafslutning (Faktiske)
24. juni 2026
Datoer for studieregistrering
Først indsendt
29. juni 2026
Først indsendt, der opfyldte QC-kriterier
29. juni 2026
Først opslået (Faktiske)
6. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
29. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Cerebrovaskulære lidelser
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Karsygdomme
- Hjerte-kar-sygdomme
- Patologiske processer
- Blødning
- Lammelse
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Slag
- Intrakranielle blødninger
- Hemiplegi
- Diagnostiske teknikker og procedurer
- Diagnose
- Diagnostiske teknikker, neurologisk
- Elektrodiagnose
- Nerve ledningsundersøgelser
Andre undersøgelses-id-numre
- BASKENT UNIVERSITY KA24/315
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
IPD-planbeskrivelse
A decision regarding the sharing of individual participant data has not yet been made.
Data sharing will be considered after completion of the study and publication of the primary results, in accordance with institutional policies, ethical requirements, and applicable regulations.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .